Soft tissue sarcoma, Womb (uterine or endometrial) cancer
Results
Phase 2
This trial looked at cabozantinib as for high grade uterine sarcoma that had stopped growing or got smaller after initial chemotherapy. This is also called high grade sarcoma of the womb.
The women who took part either had chemotherapy after surgery, or as the first treatment for cancer that had spread (advanced cancer).
This trial was supported by Cancer Research UK. People could join the trial between 2015 and 2021. The team presented the results at a conference in 2026.
Recruitment start: 6 May 2016
Recruitment end: 30 June 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Helen Hatcher
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
Exelixis
Experimental Cancer Medicine Centre (ECMC)
Glasgow Oncology Clinical Trials Unit
International Rare Cancer Initiative (IRCI)
NHS Greater Glasgow and Clyde
La Ligue Nationale Contre le Cancer
The de Spoelberch family
Last reviewed: 26 Jun 2026
CRUK internal database number: 11734
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
